• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diabetes Mellitus With Coronary Artery Disease: Identifying Subgroups in Need of Additional Monitoring.

作者信息

Kwon Woochan, Song Young Bin

机构信息

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

JACC Asia. 2022 Apr 12;2(3):309-310. doi: 10.1016/j.jacasi.2022.02.006. eCollection 2022 Jun.

DOI:10.1016/j.jacasi.2022.02.006
PMID:36338403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9627823/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6948/9627823/ab36e4f8caad/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6948/9627823/ab36e4f8caad/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6948/9627823/ab36e4f8caad/fx1.jpg

相似文献

1
Diabetes Mellitus With Coronary Artery Disease: Identifying Subgroups in Need of Additional Monitoring.糖尿病合并冠状动脉疾病：识别需要额外监测的亚组
JACC Asia. 2022 Apr 12;2(3):309-310. doi: 10.1016/j.jacasi.2022.02.006. eCollection 2022 Jun.
2
Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.既往经皮冠状动脉介入治疗对糖尿病合并三支血管病变行冠状动脉旁路移植术患者的预后影响。
J Thorac Cardiovasc Surg. 2007 Aug;134(2):470-6. doi: 10.1016/j.jtcvs.2007.04.019.
3
Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?糖尿病患者的心肌血运重建：冠状动脉旁路移植术还是经皮冠状动脉介入治疗？
Ann Thorac Surg. 2016 Sep;102(3):1012-1022. doi: 10.1016/j.athoracsur.2016.02.081. Epub 2016 May 21.
4
Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting.糖尿病患者与曾接受冠状动脉搭桥术的非糖尿病患者经皮冠状动脉介入治疗的比较结果。
Eur Heart J. 2002 Sep;23(18):1456-64. doi: 10.1053/euhj.2001.3155.
5
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease.多支血管病变及无保护左主干冠状动脉疾病患者冠状动脉旁路移植术与第二代药物洗脱支架经皮冠状动脉介入治疗的结果
SAGE Open Med. 2017 Jan 18;5:2050312116687707. doi: 10.1177/2050312116687707. eCollection 2017.
6
Coronary artery bypass grafting versus percutaneous coronary intervention in patients with noninsulin treated type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.非胰岛素治疗的 2 型糖尿病患者行冠状动脉旁路移植术与经皮冠状动脉介入治疗的比较：一项随机对照试验的荟萃分析。
Diabetes Metab Res Rev. 2018 Jan;34(1). doi: 10.1002/dmrr.2951. Epub 2017 Oct 19.
7
Diabetes in patients undergoing coronary artery bypass grafting. Impact on perioperative outcome.接受冠状动脉搭桥手术患者的糖尿病。对围手术期结局的影响。
Z Kardiol. 2005 Sep;94(9):575-82. doi: 10.1007/s00392-005-0273-7.
8
Comparison of peri and post-procedural complications in patients undergoing revascularisation of coronary artery multivessel disease by coronary artery bypass grafting or protected percutaneous coronary intervention with the Impella 2.5 device.比较经皮冠状动脉介入治疗与冠状动脉旁路移植术联合 Impella 2.5 装置治疗冠状动脉多支血管病变患者围手术期和术后并发症。
Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):360-368. doi: 10.1177/2048872617717687. Epub 2017 Jun 29.
9
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.当前针对三支血管病变及左主干冠状动脉疾病的经皮冠状动脉介入治疗和冠状动脉旁路移植术实践。来自SYNTAX导入期的见解。
Eur J Cardiothorac Surg. 2006 Apr;29(4):486-91. doi: 10.1016/j.ejcts.2006.01.047. Epub 2006 Feb 23.
10
Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.Bypass Angioplasty Revascularization Investigation 2 Diabetes 试验中 2 型糖尿病和冠状动脉疾病治疗策略的经济结果。
Circulation. 2009 Dec 22;120(25):2550-8. doi: 10.1161/CIRCULATIONAHA.109.912709. Epub 2009 Nov 17.

引用本文的文献

1
Application of optical tweezers in cardiovascular research: More than just a measuring tool.光镊在心血管研究中的应用：不止是一种测量工具。
Front Bioeng Biotechnol. 2022 Sep 6;10:947918. doi: 10.3389/fbioe.2022.947918. eCollection 2022.

本文引用的文献

1
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry.冠状动脉血运重建术后长期预后的糖尿病风险修饰因素：CREDO-Kyoto PCI/CABG注册研究
JACC Asia. 2022 Apr 12;2(3):294-308. doi: 10.1016/j.jacasi.2021.12.012. eCollection 2022 Jun.
2
Glucose-lowering therapy in patients undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗患者的降糖治疗。
EuroIntervention. 2021 Oct 1;17(8):e618-e630. doi: 10.4244/EIJ-D-20-01250.
3
Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.
在一级和二级预防环境中，2 型糖尿病患者的危险因素控制与心血管事件风险。
Circulation. 2020 Nov 17;142(20):1925-1936. doi: 10.1161/CIRCULATIONAHA.120.046783. Epub 2020 Nov 16.